Evaluation of a Salmonella strain lacking the secondary messenger c-di-GMP and RpoS as a live oral vaccine
| dc.contributor.author | Latasa Osta, Cristina | |
| dc.contributor.author | Echeverz Sarasúa, Maite | |
| dc.contributor.author | García Ona, Enrique | |
| dc.contributor.author | Burgui Erice, Saioa | |
| dc.contributor.author | Casares, Noelia | |
| dc.contributor.author | Hervás Stubbs, Sandra | |
| dc.contributor.author | Lasarte, Juan José | |
| dc.contributor.author | Lasa Uzcudun, Íñigo | |
| dc.contributor.author | Solano Goñi, Cristina | |
| dc.contributor.author | García Martínez, Begoña | |
| dc.contributor.author | Gil Puig, Carmen | |
| dc.contributor.department | IdAB. Instituto de Agrobiotecnología / Agrobioteknologiako Institutua | es_ES |
| dc.contributor.funder | Gobierno de Navarra / Nafarroako Gobernua: IIM 13329.RI1 | es |
| dc.date.accessioned | 2016-11-04T14:12:20Z | |
| dc.date.available | 2016-11-04T14:12:20Z | |
| dc.date.issued | 2016 | |
| dc.description.abstract | Salmonellosis is one of the most important bacterial zoonotic diseases transmitted through the consumption of contaminated food, with chicken and pig related products being key reservoirs of infection. Although numerous studies on animal vaccination have been performed in order to reduce Salmonella prevalence, there is still a need for an ideal vaccine. Here, with the aim of constructing a novel live attenuated Salmonella vaccine candidate, we firstly analyzed the impact of the absence of cyclic-di-GMP (c-di-GMP) in Salmonella virulence. Cdi-GMP is an intracellular second messenger that controls a wide range of bacterial processes, including biofilm formation and synthesis of virulence factors, and also modulates the host innate immune response. Our results showed that a Salmonella multiple mutant in the twelve genes encoding diguanylate cyclase proteins that, as a consequence, cannot synthesize c-di-GMP, presents a moderate attenuation in a systemic murine infection model. An additional mutation of the rpoS gene resulted in a synergic attenuating effect that led to a highly attenuated strain, referred to as ΔXIII, immunogenic enough to protect mice against a lethal oral challenge of a S. Typhimurium virulent strain. ΔXIII immunogenicity relied on activation of both antibody and cell mediated immune responses characterized by the production of opsonizing antibodies and the induction of significant levels of IFN-γ, TNF- α, IL-2, IL-17 and IL-10. ΔXIII was unable to form a biofilm and did not survive under desiccation conditions, indicating that it could be easily eliminated from the environment. Moreover, ΔXIII shows DIVA features that allow differentiation of infected and vaccinated animals. Altogether, these results show ΔXIII as a safe and effective live DIVA vaccine | en |
| dc.description.sponsorship | CG and BG are recipients of a postdoctoral contract under Grants IIM 13329.RI1 and BIO2011-30503-C02-02, respectively. This work was supported by grant IIM 13329.RI1 from the Departamento de Innovación, Empresa y Empleo, Government of Navarra and grants BIO2011-30503- C02-02 and BIO2014-53530-R from the Spanish Ministry of Economy and Competitiveness. | en |
| dc.format.mimetype | application/pdf | en |
| dc.identifier.doi | 10.1371/journal.pone.0161216 | |
| dc.identifier.issn | 1932-6203 (Print) | |
| dc.identifier.issn | 1932-6203 (Electronic) | |
| dc.identifier.uri | https://academica-e.unavarra.es/handle/2454/22608 | |
| dc.language.iso | eng | en |
| dc.publisher | Public Library of Science | en |
| dc.relation.ispartof | PLoS ONE 11(8): e0161216 | en |
| dc.relation.projectID | info:eu-repo/grantAgreement/MICINN//BIO2011-30503-C02-02/ES/ | |
| dc.relation.projectID | info:eu-repo/grantAgreement/MINECO//BIO2014-53530-R/ES/ | |
| dc.relation.publisherversion | https://dx.doi.org/10.1371/journal.pone.0161216 | |
| dc.rights | © 2016 Latasa et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. | en |
| dc.rights.accessRights | info:eu-repo/semantics/openAccess | |
| dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
| dc.subject | Salmonella | en |
| dc.subject | Salmonellosis | en |
| dc.subject | Enzyme-linked immunoassays | en |
| dc.subject | Mouse models | en |
| dc.subject | Antibodies | en |
| dc.subject | Cytokines | en |
| dc.subject | Salmonella typhimurium | en |
| dc.subject | Vaccines | en |
| dc.title | Evaluation of a Salmonella strain lacking the secondary messenger c-di-GMP and RpoS as a live oral vaccine | en |
| dc.type | info:eu-repo/semantics/article | |
| dc.type.version | info:eu-repo/semantics/publishedVersion | en |
| dspace.entity.type | Publication | |
| relation.isAuthorOfPublication | 2b788f0c-d8f4-4dc9-bc40-72e34cc1b18c | |
| relation.isAuthorOfPublication | dce8bd64-382c-4910-ba31-734876ed6ce8 | |
| relation.isAuthorOfPublication | 59c2760a-5a01-49c3-9f8c-8bc8dd159c67 | |
| relation.isAuthorOfPublication | 37fcbeeb-a960-4b98-9677-3d84608f2be1 | |
| relation.isAuthorOfPublication | 604bf0a4-db18-46ae-b75d-f130b5fe875b | |
| relation.isAuthorOfPublication | c654d104-1ae2-41cf-9215-4b4bed3e5ea6 | |
| relation.isAuthorOfPublication | b6a392a0-c0e5-4c6f-9086-6fa4291d0856 | |
| relation.isAuthorOfPublication | 7f89244d-67ab-4c4d-b868-ad7ae9112055 | |
| relation.isAuthorOfPublication | 7fcbe5e9-956a-431c-95c6-1c988099207c | |
| relation.isAuthorOfPublication.latestForDiscovery | 2b788f0c-d8f4-4dc9-bc40-72e34cc1b18c |